Breast Carcinoma Amplified Sequence 2 (BCAS2) (C-Term) Peptide
BCAS2
适用: 人
宿主: 合成
BP, WB
-
- 抗原 See all BCAS2 products
- BCAS2 (Breast Carcinoma Amplified Sequence 2 (BCAS2))
- 蛋白结构域
- C-Term
- 宿主
- 人
-
资源
- 合成
- 应用范围
- Blocking Peptide (BP), Western Blotting (WB)
- 序列
- SKLREMESNW VSLVSKNYEI ERTIVQLENE IYQIKQQHGE ANKENIRQDF
- 产品特性
- This is a synthetic peptide designed for use in combination with anti- BCAS2 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
-
- 应用备注
- Optimal working dilution should be determined by the investigator.
- 限制
- 仅限研究用
-
- 状态
- Lyophilized
- 溶解方式
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- 储存条件
- -20 °C
- 储存方法
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- 抗原
- BCAS2 (Breast Carcinoma Amplified Sequence 2 (BCAS2))
- 别名
- DAM1 Peptide, SPF27 Peptide, Snt309 Peptide, 6430539P16Rik Peptide, AI132645 Peptide, C76366 Peptide, C80030 Peptide, BCAS2 Peptide, cb302 Peptide, zgc:101730 Peptide, BCAS2, pre-mRNA processing factor Peptide, breast carcinoma amplified sequence 2 Peptide, breast carcinoma amplified sequence 2 L homeolog Peptide, BCAS2 Peptide, Bcas2 Peptide, bcas2 Peptide, bcas2.L Peptide, CpipJ_CPIJ003889 Peptide
- 背景
-
Component of the PRP19-CDC5L complex that forms an integral part of the spliceosome and is required for activating pre-mRNA splicing. May have a scaffolding role in the spliceosome assembly as it contacts all other components of the core complex. The PRP19-CDC5L complex may also play a role in the response to DNA damage (DDR).
Alias Symbols: DAM1, SPF27, Snt309
Protein Size: 225 - 基因ID
- 10286
- NCBI登录号
- NM_005872, NP_005863
- UniProt
- O75934
-
You are here:
